Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
New data indicating underreporting of federal funding in academic biomedical patents highlight the pressing need for greater transparency under the Bayh-Dole Act.
There was a time when academia viewed industry simply as a cash cow; today, it's all about sharing common goals and mutual respect for cultural differences.